en
Nieuwsbrief
Cases

Biocartis

  • Life Sciences & Care
  • Portfolio Life Sciences & Care
  • Life sciences & care

Biocartis is an innovative company active in molecular diagnostics (MDx), offering commercial diagnostic solutions since several years.  These are designed to improve clinical practice for the benefit of patients, clinicians and the healthcare industry.

The patented MDx Idylla™ platform is a fully automated system that delivers accurate, highly reliable molecular information in real time from any biological sample and in almost any environment. Idylla™ provides an answer to the growing demand for personalised medicine by contributing to fast and effective treatment selection, as well as monitoring the progress of that treatment.

Partners in ambition at Biocartis

PMV has been a first-time investor since Biocartis was founded in 2010 and participated in several capital rounds until the IPO in 2015.